Beginning in December 2019, the world faced a critical new public health stressor with the
emergence of SARS-CoV-2. Its spread was extraordinarily rapid, and in a matter of weeks …

COVID-19 vaccines were developed and approved rapidly in response to the urgency
created by the pandemic. No specific regulations existed at the time they were marketed …

Studies are needed to evaluate the safety and effectiveness of mRNA SARS-CoV-2
vaccination during pregnancy, and the levels of protection provided to their newborns …

(1) Objective: This systematic review summarizes current knowledges about maternal and
neonatal outcomes following COVID-19 vaccination during pregnancy and breastfeeding.(2) …

In view of the scarcity of data to guide decision making, we evaluated how BNT162b2 and
mRNA-1273 vaccines affect the immune response in lactating women and the protective …

Human milk contains three antibody classes that confer mucosal immunity to the breastfed
infant: secretory IgA (SIgA), secretory IgM (SIgM), and IgG. Influenza and pertussis vaccines …

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). It is acknowledged that vulnerable …

Background: CDC guidelines have recommended coronavirus disease-19 (COVID-19)
vaccination for all people 5 years and older, including people who are breastfeeding. Breast …

Background Vaccination of lactating women against COVID-19 may protect not only
themselves but also their breastfed infant through human milk. Therefore, it is important to …

Background More than 325,000 cases of coronavirus disease 2019 (COVID‐19) have been
reported among pregnant women in the Americas. Aims This review examines the impact of …